What is the Impact Factor of Journal of Ocular Pharmacology and Therapeutics?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Ocular Pharmacology and Therapeutics is 2.20, ranking in quartile Q2 of Web of Science (SCIE).

Is Journal of Ocular Pharmacology and Therapeutics indexed in Web of Science or Scopus?

Yes, Journal of Ocular Pharmacology and Therapeutics is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.621 (Q2) and an H-index of 81.

Who publishes Journal of Ocular Pharmacology and Therapeutics and what is the Article Processing Charge (APC)?

Journal of Ocular Pharmacology and Therapeutics is published by Mary Ann Liebert Inc.. The estimated Article Processing Charge (APC) is approximately $3,005 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Journal of Ocular Pharmacology and Therapeutics?

The official ISO-4 abbreviation of Journal of Ocular Pharmacology and Therapeutics is "J OCUL PHARMACOL TH". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #9,467Hybrid

Journal of Ocular Pharmacology and Therapeutics

Abbreviation (ISO):J OCUL PHARMACOL TH

•

Identifier (ISSN):1080-7683(Print)/1557-7732(Online)

•

Publisher:Mary Ann Liebert Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.2↑ +0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Ocular Pharmacology and Therapeutics

WoS Q2

Annual Impact Factor Metric

Current (2026):2.2

Scopus SJR & RankScopus Q2

0.621

#9,467

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

81 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate5.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

71articles/year

11.32% Gold OA•95.45% Original Research

Aims & Scope

Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders. Journal of Ocular Pharmacology and Therapeutics coverage includes: Glaucoma Cataracts Retinal degeneration Ocular infection, trauma, and toxicology Ocular drug delivery and biotransformation Ocular pharmacotherapy/clinical trials Ocular inflammatory and immune disorders Gene and cell-based therapies Ocular metabolic disorders Ocular ischemia and blood flow Proliferative disorders of the eye Eyes on Drug Discovery - written by Gary D. Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA.

Topics Covered (Recognized by AI)

Medicine99.6%Biology93.9%Ophthalmology77.7%Chemistry71.7%Internal medicine71%Psychology66.3%Biochemistry61.3%Surgery58.7%Genetics57.1%Physics55.2%Neuroscience53.8%Pharmacology43.8%Psychiatry43.5%Endocrinology42.4%Optics42.2%Pathology35%Organic chemistry32%Intraocular pressure28.3%Anesthesia27.7%Immunology23.8%Glaucoma23.1%Botany21%

Primary Research Areas

Medicine Ophthalmology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

OPHTHALMOLOGY

Rank43/98

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank231/356

IndexSCIE

JCISCIE2026

OPHTHALMOLOGY

Rank55/98

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank161/356

IndexSCIE

Category	Index	Rank	Quartile
OPHTHALMOLOGY	JCRSCIE	43/98	Q2
PHARMACOLOGY & PHARMACY	JCRSCIE	231/356	Q3
OPHTHALMOLOGY	JCISCIE	55/98	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	161/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.2

Articles / Year76

Total Citations10

2025

IF2.1

Articles / Year92

Total Citations121

2024

IF1.9

Articles / Year83

Total Citations277

2023

IF2.3

Articles / Year90

Total Citations542

2022

IF2.85

Articles / Year78

Total Citations669

Year	Impact Factor	Articles / Year	Total Citations
2026	2.2	76	10
2025	2.1	92	121
2024	1.9	83	277
2023	2.3	90	542
2022	2.85	78	669
2021	2.671	86	861
2020	1.925	93	1,585
2019	1.792	92	1,356
2018	1.921	85	1,545
2017	—	118	2,612
2016	—	101	1,729
2015	—	105	2,420

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,467Scopus Q2SCImago Profile

Scopus Coverage:1985-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.621

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.13

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,005 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations616

3-Year Documents252

Citable Documents226

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OphthalmologyQ2

PharmacologyQ2

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 5.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

3区OPHTHALMOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Ocular Pharmacology and Therapeutics (abbr: J OCUL PHARMACOL TH, ISSN: 1080-7683) is a peer-reviewed international scholarly journal in the field of Medicine, published by Mary Ann Liebert Inc. in United States since 1995. The periodical holds a Journal Impact Factor (JIF) of 2.20, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.621 (Q2), an H-index of 81.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 71 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,005 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.